217 related articles for article (PubMed ID: 1588167)
1. The P6 outer membrane protein of nontypeable Haemophilus influenzae as a vaccine antigen.
Murphy TF; Nelson MB; Apicella MA
J Infect Dis; 1992 Jun; 165 Suppl 1():S203-5. PubMed ID: 1588167
[No Abstract] [Full Text] [Related]
2. Molecular conservation of the P6 outer membrane protein among strains of Haemophilus influenzae: analysis of antigenic determinants, gene sequences, and restriction fragment length polymorphisms.
Nelson MB; Munson RS; Apicella MA; Sikkema DJ; Molleston JP; Murphy TF
Infect Immun; 1991 Aug; 59(8):2658-63. PubMed ID: 1713197
[TBL] [Abstract][Full Text] [Related]
3. Developing a vaccine to prevent otitis media caused by nontypeable Haemophilus influenzae.
Khan MN; Ren D; Kaur R; Basha S; Zagursky R; Pichichero ME
Expert Rev Vaccines; 2016 Jul; 15(7):863-78. PubMed ID: 26894630
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of the 26-kilodalton outer membrane protein and two P5 fimbrin-derived immunogens to induce clearance of nontypeable Haemophilus influenzae from the rat middle ear and lungs as well as from the chinchilla middle ear and nasopharynx.
Kyd JM; Cripps AW; Novotny LA; Bakaletz LO
Infect Immun; 2003 Aug; 71(8):4691-9. PubMed ID: 12874350
[TBL] [Abstract][Full Text] [Related]
5. Intranasal vaccination with recombinant P6 protein and adamantylamide dipeptide as mucosal adjuvant confers efficient protection against otitis media and lung infection by nontypeable Haemophilus influenzae.
Bertot GM; Becker PD; Guzmán CA; Grinstein S
J Infect Dis; 2004 Apr; 189(7):1304-12. PubMed ID: 15031801
[TBL] [Abstract][Full Text] [Related]
6. Immunogenicity of Nontypeable Haemophilus influenzae Outer Membrane Vesicles and Protective Ability in the Chinchilla Model of Otitis Media.
Winter LE; Barenkamp SJ
Clin Vaccine Immunol; 2017 Oct; 24(10):. PubMed ID: 28768669
[TBL] [Abstract][Full Text] [Related]
7. Developing a nontypeable Haemophilus influenzae (NTHi) vaccine.
Poolman JT; Bakaletz L; Cripps A; Denoel PA; Forsgren A; Kyd J; Lobet Y
Vaccine; 2000 Dec; 19 Suppl 1():S108-15. PubMed ID: 11163473
[TBL] [Abstract][Full Text] [Related]
8. Protection against development of otitis media induced by nontypeable Haemophilus influenzae by both active and passive immunization in a chinchilla model of virus-bacterium superinfection.
Bakaletz LO; Kennedy BJ; Novotny LA; Duquesne G; Cohen J; Lobet Y
Infect Immun; 1999 Jun; 67(6):2746-62. PubMed ID: 10338477
[TBL] [Abstract][Full Text] [Related]
9. Serum Concentrations of Antibodies against Outer Membrane Protein P6, Protein D, and T- and B-Cell Combined Antigenic Epitopes of Nontypeable Haemophilus influenzae in Children and Adults of Different Ages.
Hua CZ; Hu WL; Shang SQ; Li JP; Hong LQ; Yan J
Clin Vaccine Immunol; 2016 Feb; 23(2):155-61. PubMed ID: 26677200
[TBL] [Abstract][Full Text] [Related]
10. Immunological characterisation of truncated lipooligosaccharide-outer membrane protein based conjugate vaccine against Moraxella catarrhalis and nontypeable Haemophilus influenzae.
Singh S; Wilson JC; Cripps AW; Massa H; Ozberk V; Grice ID; Peak IR
Vaccine; 2020 Jan; 38(2):309-317. PubMed ID: 31668366
[TBL] [Abstract][Full Text] [Related]
11. Bactericidal antibody response against P6, protein D, and OMP26 of nontypeable Haemophilus influenzae after acute otitis media in otitis-prone children.
Khan MN; Kaur R; Pichichero ME
FEMS Immunol Med Microbiol; 2012 Aug; 65(3):439-47. PubMed ID: 22463053
[TBL] [Abstract][Full Text] [Related]
12. Effect of lipid modification on the physicochemical, structural, antigenic and immunoprotective properties of Haemophilus influenzae outer membrane protein P6.
Yang YP; Munson RS; Grass S; Chong P; Harkness RE; Gisonni L; James O; Kwok Y; Klein MH
Vaccine; 1997 Jun; 15(9):976-87. PubMed ID: 9261944
[TBL] [Abstract][Full Text] [Related]
13. Immune response of young children vaccinated with Haemophilus influenzae type b conjugate vaccines.
Madore DV; Phipps DC; Eby R; Johnson CL; Smith DH
Contrib Microbiol Immunol; 1989; 10():125-50. PubMed ID: 2684505
[No Abstract] [Full Text] [Related]
14. Studies on P6, an important outer-membrane protein antigen of Haemophilus influenzae.
Nelson MB; Murphy TF; van Keulen H; Rekosh D; Apicella MA
Rev Infect Dis; 1988; 10 Suppl 2():S331-6. PubMed ID: 3055201
[TBL] [Abstract][Full Text] [Related]
15. Construction of a mutant and characterization of the role of the vaccine antigen P6 in outer membrane integrity of nontypeable Haemophilus influenzae.
Murphy TF; Kirkham C; Lesse AJ
Infect Immun; 2006 Sep; 74(9):5169-76. PubMed ID: 16926409
[TBL] [Abstract][Full Text] [Related]
16. Haemophilus influenzae vaccine candidate outer membrane protein P6 is not conserved in all strains.
Chang A; Kaur R; Michel LV; Casey JR; Pichichero M
Hum Vaccin; 2011 Jan; 7(1):102-5. PubMed ID: 21285530
[TBL] [Abstract][Full Text] [Related]
17. Vaccines for Nontypeable Haemophilus influenzae: the Future Is Now.
Murphy TF
Clin Vaccine Immunol; 2015 May; 22(5):459-66. PubMed ID: 25787137
[TBL] [Abstract][Full Text] [Related]
18. Promiscuous peptides on the nontypeable Haemophilus influenzae P6 outer membrane protein.
Nomura Y; Abe Y; Ishida Y; Kobayashi H; Harabuchi Y
J Clin Immunol; 2008 Jul; 28(4):361-9. PubMed ID: 18379862
[TBL] [Abstract][Full Text] [Related]
19. Role of an immunodominant T cell epitope of the P6 protein of nontypeable Haemophilus influenzae in murine protective immunity.
McMahon M; Murphy TF; Kyd J; Thanavala Y
Vaccine; 2005 May; 23(27):3590-6. PubMed ID: 15855018
[TBL] [Abstract][Full Text] [Related]
20. Nasal immunization with plasmid DNA encoding P6 protein and immunostimulatory complexes elicits nontypeable Haemophilus influenzae-specific long-term mucosal immune responses in the nasopharynx.
Kodama S; Hirano T; Noda K; Umemoto S; Suzuki M
Vaccine; 2011 Feb; 29(10):1881-90. PubMed ID: 21237276
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
